GPT and metabolic dysfunction-associated steatotic liver disease: With further additional adjustment for NAFLD in model 3, the results indicated that ALT and GGT levels in quartile 4 had an approximately 1.58-fold and 2.27-fold higher risk of developing T2D compared with ALT and GGT in the lowest quartile, respectively.